Plantar Fibromatosis — Trials

Plantar Fibromatosis — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06151197	Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)(STRIDE)	completed	Phase 3	436	Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY	2	Jul 13, 2026	clinicaltrials
NCT05152173	Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis	completed	Phase 2	176	Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY	1	Mar 27, 2026	clinicaltrials
NCT05254457	Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis	completed	Phase 3	145	Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY	1	Mar 21, 2025	clinicaltrials
NCT03507010	Ledderhose Disease: Radiotherapy or Not?(LedRad)	active not recruiting

Data updated 22 days agoSource updated Jul 13, 2026source: clinicaltrials